Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -464.87% | -46.09% | 88.29% | -701.37% | -191.17% |
| Total Depreciation and Amortization | -31.43% | -1.06% | 0.52% | 0.38% | -14.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 397.02% | 247.17% | -94.81% | 742.81% | 100.76% |
| Change in Net Operating Assets | 401.91% | 23.26% | 69.51% | -169.22% | 183.72% |
| Cash from Operations | 94.17% | 552.69% | 104.93% | -143.57% | 458.58% |
| Capital Expenditure | 55.93% | 11.59% | 18.87% | 0.88% | 1.09% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,110.23% | 98.66% | -446.65% | 72.14% | -187.67% |
| Cash from Investing | -1,264.31% | 92.80% | -246.12% | 65.34% | -206.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 4.60% | -- | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.75% | 90.79% | -90,200.00% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,653.28% | 102.14% | -73.86% | -371.54% | -121.73% |